FDA 8% fund increase bid
February 12, 2016
United States Food and Drug
Administration (FDA) is fighting for
a total budget of $5.1b to protect
and promote the public’s health as
part of the President’s fiscal year
2017 budget, representing an eight
percent increase over the enacted
budget for FY 2016.
What could be interpreted as an
ambit claim, the FDA is seeking a
net increase of $14.6m in budget
authority and $268.7 million in
user fees for initiatives tied to
several key areas, including the
implementation of the FDA Food
Safety Modernization Act (FMSA)
and efforts to improve medical
product safety and quality.
The agency has said it is also
seeking $75m in new mandatory
funding to support the National
Cancer Moonshot initiative being
led by the Vice President (PD 21
Jan).
FDA Acting Commissioner
Stephen Ostroff said, “The FDA
continues to work to obtain
the most public health value
for the federal dollar as we
address expanded regulatory
responsibilities and scientific
challenges.”
This will require more than $3m
in building and faciities funding, he
said, along with some $600,000 for
other infrastructure.
“The agency remains fully
committed to meeting the needs
and high expectations of the
American people regarding the
products we regulate, as well
as advancing the prevention,
screening, diagnosis, and treatment
of cancer,” Ostroff explained.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Feb 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Feb 16
